{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:04Z","timestamp":1787166484509,"version":"build-2736575974"},"reference-count":42,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0557","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T17:06:54Z","timestamp":1607706414000},"page":"1-6","source":"Crossref","is-referenced-by-count":31,"title":["Proposal of diagnostic criteria for IgG4-related thyroid disease"],"prefix":"10.1507","volume":"68","author":[{"given":"Ken","family":"Takeshima","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong, 250021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennichi","family":"Kakudo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Izumi 594-0073, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Advanced Medical Care Center, Kusatsu General Hospital, Kusatsu 525-8585, Japan"},{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Nara Medical University Hospital, Nara 634-8522, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"},{"name":"Department of Internal Medicine, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, et al. (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732\u2013738.","DOI":"10.1056\/NEJM200103083441005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366: 539\u2013551.","DOI":"10.1056\/NEJMra1104650"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, et al. (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 22: 21\u201330.","DOI":"10.3109\/s10165-011-0571-z"},{"key":"4","unstructured":"4 Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, et al. (2015) IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94: e680."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Uchida K, Masamune A, Shimosegawa T, Okazaki K (2012) Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol 2012: 358371.","DOI":"10.1155\/2012\/358371"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Brito-Zer\u00f3n P, Ramos-Casals M, Bosch X, Stone JH (2014) The clinical spectrum of IgG4-related disease. Autoimmun Rev 13: 1203\u20131210.","DOI":"10.1016\/j.autrev.2014.08.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Masaki Y, Sugai S, Umehara H (2010) IgG4-related disease including Mikulicz\u2019s disease and sclerosing pancreatitis: diagnostic insights. J Rheum 37: 1380\u20131385.","DOI":"10.3899\/jrheum.091153"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kawano M, Saeki S, Nakashima H, Nishi S, Yamaguchi Y, et al. (2011) Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 15: 615\u2013626.","DOI":"10.1007\/s10157-011-0521-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Takagi H, Iwama S, Sugimura Y, Takahashi Y, Oki Y, et al. (2020) Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society. Endocr J 67: 373\u2013378.","DOI":"10.1507\/endocrj.EJ19-0569"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kamisawa T, Takuma K, Tabata T, Inaba Y, Egawa N, et al. (2011) Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol 46: 108\u2013116.","DOI":"10.1007\/s00535-010-0317-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74: 14\u201318.","DOI":"10.1136\/annrheumdis-2013-204907"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, et al. (2020) The 2019 American college of rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72: 7\u201319.","DOI":"10.1002\/art.41120"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Watanabe T, Maruyama M, Ito T, Fujinaga Y, Ozaki Y, et al. (2013) Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol 42: 325\u2013330.","DOI":"10.3109\/03009742.2012.761281"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kottahachchi D, Topliss DJ (2016) Immunoglobulin G4-related thyroid diseases. Eur Thyroid J 5: 231\u2013239.","DOI":"10.1159\/000452623"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, et al. (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto\u2019s autoimmune thyroiditis. Pathol Int 59: 636\u2013641.","DOI":"10.1111\/j.1440-1827.2009.02419.x"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 Li Y, Wang X, Liu Z, Ma J, Lin X, et al. (2020) Hashimoto\u2019s thyroiditis with increased IgG4-positive plasma cells: using thyroid-specific diagnostic criteria may identify early-phase IgG4 thyroiditis. Thyroid 30: 251\u2013261.","DOI":"10.1089\/thy.2019.0063"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, et al. (2010) Distinct clinical, serological, and sonographic characteristics of Hashimoto\u2019s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 95: 1309\u20131317.","DOI":"10.1210\/jc.2009-1794"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Kakudo K, Li Y, Taniguchi E, Mori I, Ozaki T, et al. (2012) IgG4-related disease of the thyroid glands. Endocr J 59: 273\u2013281.","DOI":"10.1507\/endocrj.EJ11-0309"},{"key":"19","unstructured":"19 Hubers LM, Vos H, Schuurman AR, Erken R, Oude Elferink RP, et al. (2018) Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut 67: 728\u2013735."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Perugino CA, AlSalem SB, Mattoo H, Della-Torre E, Mahajan V, et al. (2019) Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol 143: 736\u2013745.","DOI":"10.1016\/j.jaci.2018.05.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, et al. (2018) Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med 10: eaaq0997.","DOI":"10.1126\/scitranslmed.aaq0997"},{"key":"22","first-page":"239","volume":"57","author":"AB Parkes","year":"1984","unstructured":"22 Parkes AB, McLachlan SM, Bird P, Smith BR (1984) The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol 57: 239\u2013243.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Inomata K, Kurisaki H, Yamashita H, Sato S, Tachibana S, et al. (2018) Identification of thyroglobulin and its isoforms as target antigens for IgG4 thyroiditis. J Clin Cell Immunol 9: 568.","DOI":"10.4172\/2155-9899.1000568"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Takeshima K, Ariyasu H, Inaba H, Inagaki Y, Yamaoka H, et al. (2015) Distribution of serum immunoglobulin G4 levels in Hashimoto\u2019s thyroiditis and clinical features of Hashimoto\u2019s thyroiditis with elevated serum immunoglobulin G4 levels. Endocr J 62: 711\u2013717.","DOI":"10.1507\/endocrj.EJ15-0157"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180: R175\u2013R183.","DOI":"10.1530\/EJE-18-1024"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Komatsu K, Hamano H, Ochi Y, Takayama M, Muraki T, et al. (2005) High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 50: 1052\u20131057.","DOI":"10.1007\/s10620-005-2703-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ceresini G, Urban ML, Corradi D, Lauretani F, Marina M, et al. (2015) Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study. Autoimmun Rev 14: 16\u201322.","DOI":"10.1016\/j.autrev.2014.08.006"},{"key":"28","unstructured":"28 Riedel BM (1986) Die chronische, zur Bildung eisenharter Tumoren f\u00fchrende Entz\u00fcndung der Schilddr\u00fcse (The chronic inflammation of the thyroid gland leading to the formation of iron-hard tumors). Verh Dtsch Ges Chir 25: 101\u2013105 (In German)."},{"key":"29","unstructured":"29 Singer PA (2013) Primary hypothyroidism due to other causes. In: Braverman LE, Cooper DS (ed) Werner & Ingbar\u2019s the thyroid: a fundamental and clinical text (10th). Lippincott Williams & Wilkins, Philadelphia, USA: 552."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V (2011) Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976\u20132008. Thyroid 21: 765\u2013772.","DOI":"10.1089\/thy.2010.0453"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH (2010) Riedel\u2019s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 62: 1312\u20131318.","DOI":"10.1002\/acr.20215"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hennessey JV (2011) Riedel\u2019s thyroiditis: a clinical review. J Clin Endocrinol Metab 96: 3031\u20133041.","DOI":"10.1210\/jc.2011-0617"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Soh SB, Pham A, O\u2019Hehir RE, Cherk M, Topliss DJ (2013) Novel use of rituximab in a case of Riedel\u2019s thyroiditis refractory to glucocorticoids and tamoxifen. J Clin Endocrinol Metab 98: 3543\u20133549.","DOI":"10.1210\/jc.2012-4050"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34 Pusztaszeri M, Triponez F, Pache JC, Bongiovanni M (2012) Riedel\u2019s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 22: 964\u2013968.","DOI":"10.1089\/thy.2011.0404"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Takeshima K, Inaba H, Ariyasu H, Furukawa Y, Doi A, et al. (2015) Clinicopathological features of Riedel\u2019s thyroiditis associated with IgG4-related disease in Japan. Endocr J 62: 725\u2013731.","DOI":"10.1507\/endocrj.EJ15-0175"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36 Takeshima K, Inaba H, Furukawa Y, Nishi M, Yamaoka H, et al. (2014) Elevated serum immunoglobulin G4 levels in patients with Graves\u2019 disease and their clinical implications. Thyroid 24: 736\u2013743.","DOI":"10.1089\/thy.2013.0448"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Torimoto K, Okada Y, Kurozumi A, Narisawa M, Arao T, et al. (2017) Clinical features of patients with Basedow\u2019s disease and high serum IgG4 levels. Intern Med 56: 1009\u20131013.","DOI":"10.2169\/internalmedicine.56.7824"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Nishihara E, Hirokawa M, Takamura Y, Ito M, Nakamura H, et al. (2013) IgG4 thyroiditis in a Graves\u2019 disease patient with large goiter developing hypothyroidism. Thyroid 23: 1496\u20131497.","DOI":"10.1089\/thy.2013.0181"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Nishihara E, Hirokawa M, Ito M, Fukata S, Nakamura H, et al. (2015) Graves\u2019 disease patients with persistent hyperthyroidism and diffuse lymphoplasmacytic infiltration in the thyroid show no histopathological compatibility with IgG4-related disease. PLoS One 10: e0134143.","DOI":"10.1371\/journal.pone.0134143"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Latrofa F, Chazenbalk GD, Pichurin P, Chen CR, McLachlan SM, et al. (2004) Affinity-enrichment of thyrotropin receptor autoantibodies from Graves\u2019 patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J Clin Endocrinol Metab 89: 4734\u20134745.","DOI":"10.1210\/jc.2003-032068"},{"key":"41","unstructured":"41 Takeshima K, Akamizu T (2019) The association between Graves\u2019 disease, IgG4 thyroiditis and IgG4-related disease. Journal of the Japan Thyroid Association 10: 25\u201329 (In Japanese)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, et al. (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25: 1181\u20131192.","DOI":"10.1038\/modpathol.2012.72"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/1\/68_EJ20-0557\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T22:23:08Z","timestamp":1611958988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/1\/68_EJ20-0557\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0557","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}